Why the study?
Does Platelet-activating factor (PAF) and its interaction with norepinephrine and K+ induce ventricular arrhythmias in rat isolated hearts?
Population
Rat isolated hearts (ischaemia-free in vitro heart bioassay)
Design
Preclinical
Authors
Loading...
PAF arrhythmogenicity in isolated hearts may not translate to humans; leaves open whether selective blockade prevents clinical VF.
Does Platelet-activating factor (PAF) and its interaction with norepinephrine and K+ induce ventricular arrhythmias in rat isolated hearts?
PAF contributes to arrhythmogenesis, but its complex interactions with other ischaemic mediators suggest that selectively blocking PAF alone is unlikely to prevent ventricular fibrillation or sudden cardiac death.
Baker et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: